| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 24.647 | 51.689 | 53.838 | 55.165 | 60.249 | 75.380 | 99.248 |
| Total Income - EUR | - | - | 0 | 24.647 | 51.689 | 55.905 | 55.166 | 60.250 | 75.380 | 99.249 |
| Total Expenses - EUR | - | - | 42 | 15.084 | 30.415 | 37.999 | 36.973 | 38.126 | 35.461 | 45.265 |
| Gross Profit/Loss - EUR | - | - | -42 | 9.563 | 21.274 | 17.907 | 18.193 | 22.124 | 39.919 | 53.984 |
| Net Profit/Loss - EUR | - | - | -42 | 9.317 | 20.758 | 17.404 | 17.707 | 21.611 | 39.278 | 51.453 |
| Employees | - | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Sanonarcisa Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 40.867 | 59.555 | 47.430 | 33.577 | 20.840 | 13.889 | 19.509 |
| Current Assets | - | - | 45 | 7.779 | 23.668 | 22.521 | 22.551 | 30.131 | 75.675 | 68.164 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 3.173 | 4.200 | 4.442 | 4.577 | 4.087 | 11.838 | 15.248 |
| Cash | - | - | 45 | 4.606 | 19.468 | 18.079 | 17.974 | 26.044 | 63.837 | 52.915 |
| Shareholders Funds | - | - | 1 | 9.318 | 24.838 | 17.453 | 17.776 | 21.699 | 39.482 | 51.657 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 44 | 39.328 | 58.385 | 52.498 | 38.352 | 29.271 | 50.082 | 36.017 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sanonarcisa Med S.r.l.